Benzinga | Apr 15, 2021 08:44AM EDT

BioMarin Highlights Presentation Of Data At 2021 American College Of Medical Genetics And Genomics Annual Clinical Genetics Meeting

ioMarin Pharmaceutical Inc. (NASDAQ:BMRN) presented new and updated data at the 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting that demonstrates the Company's ongoing commitment to understanding the lifetime impact of achondroplasia and the potential of an investigational treatment choice to address the root cause of achondroplasia.